-+ 0.00%
-+ 0.00%
-+ 0.00%

VANDA ANNOUNCES SUBMISSION OF BIOLOGICS LICENSE APPLICATION TO THE FDA FOR IMSIDOLIMAB FOR THE TREATMENT OF GENERALIZED PUSTULAR PSORIASIS

Reuters·12/15/2025 12:00:02

Please log in to view news